Jim Cramer Says Eli Lilly's 'Pathetic' Stock Performance Could Get A Breather If Amgen Has Hidden Bone Risk Data After 7% Stock Drop

Benzinga11:12

Tradepulse Power Inflow Alert: Eli Lilly & Company Moves Up Over 13 Points After Signal

Benzinga06:41

Amgen Slips as Cantor Cites Safety Concerns Linked to Obesity Candidate

Seeking Alpha03:52

Bristol-Myers Squibb's $14 Billion Potential - Analyst Upgrades Stock

Benzinga01:48

Wells Fargo's 'Focus List' – GOOGL, TJX, XOM, JPM

Seeking AlphaNov 12 23:18

Bristol-Myers Upgraded at Leerink After AbbVie Setback

Seeking AlphaNov 12 21:22